Articles On Polynovo (ASX:PNV)

Robert F Kennedy Junior’s appointment as US health czar means an unpredictable time for ASX healthcare companies operating in the US The likely consequences are not all bad, with many stocks poised to benefit from tax cuts and a more effic...

ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7%  Neuren soars on sale of priority review voucher and $50 million share buyback Neurizon releases positive preclinical results on lead drug candidate...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are indicating a rather lacklustre start to the final week for October i...

Highlights ASX market sees fluctuation amid Wall Street’s mixed performance 4DS Memory, Image Resources, and PolyNovo show varying financial strengths Highlighted companies stand out in semiconductor, mining, and medical device sector...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

  Singapore’s medical regulator this week approved Orthocell’s leading nerve-repair device Remplir Remplir shows great promise in restoring function for paraplegics and quadriplegics Orthocell estimates the potential global market at US$33...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

There are a lot of options for investors to choose from on the Australian share market. So, let's take a look at three ASX shares from different sides of the market that analysts are tipping as buys. They are as follows: Polynovo Ltd (ASX:...

The S&P/ASX 200 Index (ASX: XJO) continues its upward momentum, recently hitting an all-time high of 8,246.2 points before closing at 8,215.8, marking a 0.29% gain. This surge follows global market trends, with investor confidence high...

The S&P/ASX 200 Index (ASX: XJO) hit another all-time record on Friday, stretching to 8,246.2 points before settling back to 8,215.8 points, up 0.29% at the time of writing. Seven ASX 200 directors have sold significant portions of t...

It's been a fairly miserable Thursday session for ASX shares so far today. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) has slipped by 0.04% and is back under 8,140 points. But let's talk about what's going on with the ResMe...

It ended up being quite a wonderful day for the S&P/ASX 200 Index (ASX: XJO) this Tuesday. The ASX 200 managed to add 0.24% to its value and closed up at 8...

No company wants sub-optimal returns on their product – and pain-management house Medical Developments International (ASX:MVP) is no exception. For some years, management has believed that customers undervalued the worth of its flagship pro...

The team at Morgans has been busy picking out its best ASX share ideas for September. These are the stocks that it thinks offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confid...

The Australian sharemarket showed positive movement in early afternoon trading on Tuesday, recovering from last week’s downturn. The benchmark S&P/ASX 200 Index rose by 0.6%, or 43.9 points, to reach 8,032, driven higher by gains in the...

Australian shares showed a notable rebound at the start of trading on Tuesday, tracking a rally from Wall Street and recovering from last week’s sell-off. The benchmark S&P/ASX 200 Index climbed 0.6% or 44.4 points to reach 8,032.5, dri...

Australian shares rebounded on Tuesday, reflecting a rally on Wall Street as investors cautiously re-entered the market following last week’s sell-off. At 11:30am, the S&P/ASX 200 is 0.86 per cent higher at 8,057.10, driven by gains in...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

After snatching a small win from the jaws of defeat yesterday, the S&P/ASX 200 Index (ASX: XJO) wasn't so lucky this Tuesday. After a bouncy session, the ASX 200 c...

ASX health stocks flat for week in line while broader markets rise of 0.5% Nanosonics has risen ~17% in the past five days on its FY24 result Mach7 falls falls as investing in growth plans push out profit expectations    Healthcare and li...

If you are looking for some new portfolio additions, then it could be worth considering Polynovo Ltd (ASX: PNV) shares. That's the view of analysts at Bell Potter, which have just upgraded the ASX 200 healthcare stock to a buy rating. What...

ASX healthcare stocks are buzzing with activity as several key players report their FY24 earnings. Among them, Clarity Pharmaceuticals Ltd (ASX: CU6), Polynovo Ltd (ASX: PNV), and Mayne Pharma Group Ltd (ASX: MYX) have delivered sound re...

You'll find that not everyone's definition of top ASX stocks is the same. Some investors prefer lower-risk blue-chip stocks, while others are willing to take a punt on higher-risk small-cap growth shares. And, of course, passive income inve...

This Monday, the S&P/ASX 200 Index (ASX: XJO) and, by extension, many ASX shares had a stellar start to the trading week. After soaring on Friday, the ASX 200 kept up the momentu...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

What are the five fastest growth shares on the ASX? Pro Medicus Ltd (ASX: PME), HUB24 Limited (ASX: HUB), Polynovo Ltd (ASX: PNV), Codan Limited (ASX: CDA) and Macquarie Technology Group (ASX: MAQ) top the list, but let me explain… Earlier...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Several ASX healthcare companies are proudly manufacturing products in Australia  Polynovo, Optiscan and Trajan Group all have manufacturing facilities in Melbourne Orthocell says government funding can boost manufacturing capabilities of...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

ASX health stocks rise 2% in past five days as broader markets lift 0.6% Morgans upgrades disinfectant device maker Nanosonics after positive trading update  Neuren receives rare paediatric disease designation from FDA for NNZ-2591 in Phel...

The S&P/ASX 200 Index (ASX: XJO) enjoyed another strong session this Wednesday, ploughing further into 8,000-point territory and resetting its all-time record...

Following Monday's market euphoria and fresh all-time highs, it was only natural for the S&P/ASX 200 Index (ASX: XJO) to experience a bit of a correction on Tuesday. Indeed, that's precisely what transpired, with the ASX 200 slipping by...

After yesterday's market euphoria and fresh all-time highs, it was only natural that the S&P/ASX 200 Index (ASX: XJO) endured a bit of a jolt back to earth this...

Owen Rask, Chief Investment Officer of Rask Invest, is back behind the mic for his second solo Question & Answer episode and a deep dive in Polynovo Ltd (ASX: PNV) on this week’s The Australian Investors Podcast. Remember, if you like t...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

It was an unpleasant Wednesday for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this hump day. After enjoying a strong session yesterday, investors reversed course to...

Australia's sharemarket fell over 50 points on Wednesday, with the S&P/ASX 200 dropping 0.7% to 7779.5, following a spike in May's consumer price index to 4%, higher than expected. Interest rate-sensitive sectors like banking, real esta...

It was a bullish Tuesday for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares over today's trading session. After starting the week off on a shaky footing yesterday, the ASX 2...

The S&P/ASX 200 Index (ASX: XJO) seemed to turn a corner this Thursday, ending the brutal two-day losing streak that the Australian share market had been on this short trading week....

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

It was yet another dire day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Thursday. After falling most days this week, the ASX 200 kept the train rolling today, sliding anot...

It was a decidedly negative end to the trading week for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Friday. After recording backsteps for mo...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The S&P/ASX 200 Index (ASX: XJO) is having a disappointing finish to the week. In afternoon trade, the benchmark index is down 0.7% to 7,824.2 points. Four ASX shares that are falling more than most today are listed below. Here's why t...

It's been a while since I initiated a new position in my ASX share portfolio. Sure, I've topped up a couple of my favourite existing positions in the past few months. But I haven't found any new investments I've liked in a while now. At lea...

If you are on the lookout for big returns to supercharge your investment portfolio, then read on. That's because analysts at Goldman Sachs have just tipped an ASX 200 stock to generate a 12-month total return of over 40%. To put that into c...

Steve Lydeamore’s advice to biotech peers seeking to do business with the US military is to be armed with a high knowledge readiness level (KRL) when it comes to interpreting acronyms such as … KRL. The head of traveller’s diarrhoea fighter...

Cash here is becoming like the orange-bellied parrot – highly endangered – despite the folding stuff continuing to be the preferred transactional means of many tradies and their customers. From this month, Macquarie Bank went completely cas...